This compound is primarily utilized in the synthesis of peptide-based drugs and pharmaceutical intermediates. Its structure, featuring both a hydroxyl group and a protected amine, makes it a valuable building block in the preparation of complex peptides, particularly in the development of protease inhibitors. The benzyloxycarbonyl (Cbz) group serves as a protective moiety for the amine, allowing selective reactions at other sites during peptide coupling processes. Additionally, its chiral centers enable the creation of stereospecific compounds, which are crucial in drug design to ensure biological activity and efficacy. It is often employed in research settings for the development of therapeutic agents targeting diseases such as HIV, cancer, and hypertension.